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Abstract: Physical exercise has been demonstrated to be neuroprotective in both clinical 
and laboratory settings. However, the exact mechanism underlying this effect is unclear. 
Our study aimed to investigate whether pre-ischemic treadmill training could serve as a 
form of ischemic preconditioning in a rat model undergoing middle cerebral artery 
occlusion (MCAO). Thirty-six rats were divided into three groups: a sham control group, a 
non-exercise with operation group and an exercise with operation group. After treadmill 
training, ischemia was induced by occluding the MCA for 2 h, followed by reperfusion. 
Half of the rats in each group were sacrificed for mRNA detection of mGluR5 and NR2B 
80 min after occlusion. The remaining animals were evaluated for neurological deficits by 
behavioral scoring and then decapitated to assess the infarct volume. The mRNA 
expression of mGluR5 and NR2B was detected by real-time PCR. The results suggest that 
pre-ischemic treadmill training may induce brain ischemic tolerance by reducing the 
mRNA levels of mGluR5 and NR2B, and thus, the results indicate that physical exercise 
might be an effective method to establish ischemic preconditioning. 
Keywords:  mGluR5;  NR2B; real-time PCR; brain ischemic tolerance; ischemic 
preconditioning 
Abbreviations: mGluR5: metabotropic glutamate receptor 5; AMPA: α-amino-3-hydroxi-
5-methyl-4-isoxazol pro-pionic acid; NMDA:  N-methyl-d-aspartate;  NR2B:  NMDA 
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receptor subunit type 2B; MPEP:  2-[
11C]Methyl-6-(2-phenylethynyl)pyridine;  GAPDH: 
glyceraldehyde-3-phosphate dehydrogenase 
 
1. Introduction  
Ischemic stroke causes devastating complications that result in a significant burden for the entire 
society [1]. Unfortunately, there are no effective strategies to successfully eliminate such 
complications, so greater attention should be given to the prevention of stroke. Accumulating evidence 
has indicated that physical exercise exerts beneficial effects on stroke injuries, including decreases in 
cerebral infarction and edema, promotion of higher survival rates and amelioration of inflammatory 
injuries [2-5]. The brain’s ability to develop a tolerance to subsequent ischemic injury after a moderate 
stimulus is known as the brain ischemic tolerance (BIT) phenomenon [6]. Several kinds of 
preconditioning that promote resistance to ischemic stroke have been studied, including ischemia [6], 
hypoxia [7] and anoxia [8]. However, these aforementioned pretreatments might not be easily applied 
as clinical intervention in individuals with risk factors for stroke. Several studies aiming to identify 
easily applied pretreatments that induce resistance to cerebral ischemia have suggested that pre-
exercise with treadmill training may reduce risk factors for stroke [3,5,9]. 
Excessive release of glutamate after a stroke has been shown to lead to neuronal excitotoxicity and 
subsequent brain damage [10,11]. Glutamate receptor antagonists, such as those that target NR2B and 
mGluR5, have been shown to reduce brain damage after stroke [12,13]. Likewise, we previously 
showed that pre-ischemic treadmill training can down-regulate the excessive release of glutamate after 
ischemic stroke [14]. Therefore, we sought to explore whether pre-exercise with treadmill training 
directly affected glutamate receptors to clarify the mechanism underlying the neuroprotective effects 
of physical exercise. The striatum is known to be one of the core regions that is vulnerable to ischemic 
insult and enriched in glutamatergic neurons. According to our recently published paper [15], pre-
ischemic training could influence this region by regulating the mGluR1. Furthermore, in our previous 
study, we found that the level of glutamate in the striatum increased to its peak value nearly 80 min 
after the occlusion of the middle cerebral artery (MCA) [14]. Therefore, we quantified the mRNA 
levels of NR2B and mGluR5 in the striatum by real-time PCR at this time point. Our results indicate 
that treadmill training down-regulated the expression of NR2B and mGluR5, possibly contributing to 
the brain ischemic tolerance induced by pre-exercise with treadmill training. 
2. Results and Discussion  
2.1. Physiological Variables  
Animals were divided into a sham group, an exercise with operation group and a non-exercise with 
operation group. There were no significant differences observed in paO2 (partial pressure of oxygen in 
arterial blood), paCO2 (partial pressure of carbon dioxide in artery), or pH (hydrogen ion 
concentration) values between the sham, non-exercise with stroke and exercise with stroke groups 
before and after MCAO (Table 1). Int. J. Mol. Sci. 2010, 11                 
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Table 1. Physiological variables among different groups before and after MCAO. 
  Before ischemia  After ischemia 
Sham  
pH 
pCO2 (mmHg) 
pO2 (mmHg) 
 
7.22 ± 0.01 
42.8 ± 3.5 
103.8 ± 5.64 
 
7.23 ± 0.01 
43.1 ± 1.9 
103.6 ± 2.5 
Exercise 
pH 
pCO2 (mmHg) 
pO2 (mmHg) 
 
7.22 ± 0.02 
42.1 ± 2.2 
102.9 ± 3.5 
 
7.22 ± 0.03 
42.5 ± 4.5 
104.0 ± 3.3 
Non-exercise 
pH 
pCO2 (mmHg) 
pO2 (mmHg) 
 
7.23 ± 0.04 
41.9 ± 3.1 
102.8 ± 3.8 
 
7.22 ± 0.05 
42.6 ± 2.4 
103.1 ± 5.7 
No significant differences were observed in paO2, paCO2, or pH among the sham, non-exercise 
with stroke and exercise with stroke groups before and after MCAO. Data represent   
means ± standard error of the mean (S.E.M). 
2.2. Relative NR2B and mGluR5 mRNA Expression Levels among the Three Groups 
Extracts from the striatum of the treated rats and sham controls (from rats decapitated 80 min after 
occlusion) were subjected to quantitative real-time PCR analysis.  
NR2B expression was significantly lower in the exercise group compared to the sham group and the 
non-exercise group (P < 0.05), as indicated in Figure 1. There was also a significant difference in the 
relative NR2B expression between the non-exercise group and the sham group (P < 0.05).  
Figure 1. Real-time PCR analysis of relative NR2B mRNA expression levels in the 
striatum. Data are mean ± S.E.M (n = 6). There was significant difference (F(2,15) = 16.24, 
P = 0.001) among the three groups studied. Signs indicate statistically signiﬁcant 
difference (P < 0.05) in NR2B expression level between: the exercise with operation group 
and the sham control group 
* or the non-exercise with operation group 
†; between the  
non-exercise group and the sham group 
#. 
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In regard to mGluR5, there was no significant difference in mGluR5 expression between the non-
exercise group and the sham group (P > 0.05). However, mGluR5 expression was significantly 
decreased in the exercise group compared to the sham group and the non-exercise group (P < 0.05), as 
indicated in Figure 2.  
Figure 2.  Real-time PCR analysis of relative mGluR5 mRNA expression levels in the 
striatum. Data are mean ± S.E.M (n = 6). Signs indicate statistically signiﬁcant difference 
(P < 0.05) in mGluR5 expression level between the exercise with operation group and the 
sham control group 
* or the non-exercise with operation group 
†. There was no significant 
difference in relative to mGluR5 expression between the non-exercise group and the sham 
group (P > 0.05). 
 
2.3. Behavioral Scores 
Rats in the sham group, exercise with operation group and non-exercise with operation group, were 
evaluated 24 h after reperfusion. In the sham control group, none of the rats demonstrated neurological 
symptoms. In contrast, there was a signiﬁcant difference in behavior scores between the exercise with 
operation and the non-exercise with operation groups (P < 0.05), as shown in Figure 3. The rats in the 
exercise with operation group showed fewer neurological deficits than those in the non-exercise with 
operation group.  
Figure 3. Behavioral scores of the exercise group and the non-exercise group. Data are 
mean ± S.D. (n = 6). The behavioral evaluation scores for the sham group were all zero.  
*
 indicates a statistically signiﬁcant difference observed in the mean behavioral scores 
between the exercise group and the non-exercise group (P < 0.05).
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2.4. Infarct Volume 
After behavioral evaluation, 18 rats were sacrificed to determine the infarct volume. None of the 
rats in the sham control group exhibited ischemic areas. In contrast, there was a signiﬁcant difference 
in infarct volume between the exercise with operation and the non-exercise with operation groups  
(P < 0.05), as indicated in Figure 4. The rats in the exercise with operation group showed a 
significantly reduced ischemic area in the brain relative to those in the non-exercise with   
operation group. 
Figure 4. Difference in infarct volume between the exercise group and the non-exercise 
group. Top panel: Data are mean ± S.E. (n = 6). The infarct volume of the sham group of 
six rats was zero (not shown). 
* denotes a statistically signiﬁcant difference in the mean 
infarct volumes of the exercise group and the non-exercise group (P < 0.05). Bottom panel: 
2 mm coronal sections show ischemia (pale regions) and healthy tissue (red). 
 
 
2.5. Discussion 
The glutamatergic system plays a key role in normal cerebral function and regulates the activity of 
glutamate, the most abundant neurotransmitter in the central nervous system (CNS), as well as 
ionotropic NMDA, AMPA and KA (kainic acid) receptors and metabotropic G protein-coupled 
receptors [16]. Furthermore, it is well known that glutamate signaling contributes to brain injury after Int. J. Mol. Sci. 2010, 11                 
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stroke. Based on these findings, it has been suggested that targeting these glutamate receptor sub-types 
may serve as a novel therapeutic approach to treat stroke [17]. 
According to previous studies, group I mGluRs (including mGluR1 and mGluR5) are especially 
important for the regulation of pyramidal cell excitability [18,19]. Furthermore, antagonists of group I 
mGluRs appear to be neuroprotective, while agonists can aggravate or alleviate neuronal cell death in 
vitro [20-22]. In addition, a previous study demonstrated that the selective mGluR5 antagonist MPEP 
signiﬁcantly reduced neuronal damage and improved neurological recovery in an animal model of 
focal cerebral ischemia [23]. The above observations are further supported by another report, which 
showed that MPEP and its structurally related selective mGluR5 antagonist SIB-1893 signiﬁcantly 
mitigated post-traumatic cell damage in vitro and improved functional recovery in vivo [24]. Another 
study demonstrated stronger neuroprotective effects of mGluR5 antagonists compared to mGluR1 
antagonists [25]. Thus, inhibiting hyperactivation of mGluR5 after ischemic stroke appears to be 
neuroprotective. 
Other studies examining ionotropic NMDA receptors have implicated these ion channels in the 
induction of ischemic tolerance both in vitro and in vivo. Previous in vivo studies demonstrated that the 
NMDA receptor-dependent cellular signaling pathway contributes to the mechanism of ischemic 
tolerance and that new protein synthesis is also required in this process [26-28] In addition, a NMDA 
receptor non-competitive antagonist attenuated ischemic tolerance, whereas an AMPA receptor 
antagonist had no effect, thereby indicating that the NMDA receptor, but not the AMPA receptor, 
might be involved in the induction of ischemia tolerance [29]. 
In vitro, NMDA-type glutamate receptors have proved to be involved in both neuronal ischemic 
injury and ischemic tolerance [30]. Additionally, inhibiting NR2B attenuated ischemic cell death and 
strengthened preconditioning-induced neuroprotection [12].  
Therefore, it seems that a drug that can influence NMDA-type glutamate receptors could be utilized 
to treat ischemic stroke. However, the development of NMDA receptor-specific drugs has been 
hindered by their serious side effects observed in clinical trials [31,32]. Thus, clarifying the molecular 
mechanisms by which glutamate receptors exert their functions in ischemic tolerance may offer a 
potential breakthrough for the development of new methods that prevent subsequent damage after 
stroke but have fewer side effects.  
According to a previous study, both two-week and four-week pre-ischemic training could decrease 
the infarction volume and cerebral edema after MCAO [4]. Accordingly, it was reported that exercise 
preconditioning could reduce the level of inﬂammatory mediators and decrease the accumulation of 
leukocytes after cerebral occlusion/reperfusion [5]. Furthermore, pre-exercise also was able to alleviate 
cerebral permeability and strengthen brain microvascular integrity after MCAO [34]. 
In our previous study, we demonstrated that four weeks of treadmill training could down-regulate 
the excessive release of glutamate after ischemic stroke [14]. However, whether glutamate receptors 
are involved in this process is still unclear. According to a previous report, mGluR5 mRNA decreased 
significantly in ischemic preconditioning group compared to the non-preconditioning group [35]. In 
addition, in a previous in vitro study it was suggested that the mechanism of down-regulating NMDAR 
subunits mRNA levels by oxygen/glucose deprivation or glutamate receptor antagonists could be 
identical [36]. In the present study, the difference between the non-exercise group and sham group is 
whether the middle cerebral artery is occluded. Cerebral ischemia might influence expression of Int. J. Mol. Sci. 2010, 11                 
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different gene at different time point. In our experiment, we detected the relative gene expression  
80 min after occlusion. NR2B level significantly increased in the non-exercise group as compared with 
the sham group, but the similar result did not present in mGluR5 level. It is speculated that at this time 
point the cerebral ischemia influences the relative gene expression of NR2B, but not mGluR5. On the 
other hand, according to previous reports [22-29], we may conclude that antagonism of NR2B and 
mGluR5 could be neuroprotective in rats with MCAO. In our experiment, we showed that pre-training 
could reduce brain damage after cerebral ischemia. In addition, NR2B and mGluR5 level significantly 
decreased in the exercise group compared to sham group or non-exercise group. It is conjectured that 
pre-training exerts neuroprotection via inhibiting the expression of NR2B and mGluR5. In addition, the 
exercise group exhibited fewer behavioral deficits and a reduced infarct volume relative to the   
non-exercise group. These findings indicate that both NR2B and mGluR5 may contribute to the 
ischemic tolerance induced by treadmill training. 
3. Experimental Methods  
3.1. Animals 
These experiments were performed according to the guidelines of the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals. Thirty-six healthy male Sprague–Dawley rats 
(weighing 250-300 g) were provided by the Shanghai Laboratory Animal Center, Chinese Academy of 
Sciences. The rats were housed separately under a 12:12-h light/dark cycle with water and food 
available ad libitum. 
3.2. Treadmill Training 
Rats were randomly divided into three groups: a sham control group, an exercise with operation 
group and a non-exercise with operation group (12 rats in each group). The rats in the exercise group 
exercised at a speed of 6-9 m/min for 20 min per day to adapt to the running exercise. After that, the 
rats began formal training on an electric treadmill machine (DSPT-202 Type 5-Lane Treadmill; Litai 
Biotechnology Co., Ltd, China) over a period of four weeks. The formal training included a 25 m/min 
pace at a slope of 0° for 30 min/day, six days per week. The rats in the sham control group and  
non-exercise with operation group were housed freely in their cages for four weeks.  
3.3. Rat MCAO Model 
The protocol for our animal study was approved by the Animal Experimental Committee of Fudan, 
University at Shanghai, China. All rats were anesthetized intraperitoneally with chloral hydrate (10%) 
at a dose of 400 mg/kg. The body temperature was maintained by a heating pad. The rat model of 
middle cerebral artery occlusion (MCAO) was conducted according to the Zea et al. [33] with some 
modifications. Poly-L-lysine-coated intraluminal suture was used to guarantee the reliability of the 
stroke model. Such suture could yield larger infarction and significantly reduce inter-animal 
variability. First, we exposed the left common carotid artery (CCA), external carotid artery (ECA) and 
internal carotid artery (ICA). The ECA was ligated, and a small incision was made. After preparing a 
flame-rounded tip, a 20-mm long surgical suture was inserted into the internal carotid artery so as to Int. J. Mol. Sci. 2010, 11                 
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occlude the middle cerebral artery, which was held to the ECA with a thread. In the sham control 
group, all steps were the same as in the operation group except for the occlusion of the middle cerebral 
artery. For half of the rats in each group, the suture was removed 2 h after occlusion. In order to 
measure physiological parameters, both 10 min before and after, MCAO blood samples were obtained 
from the femoral artery to detect pH, arterial partial pressure of oxygen (paO2) and carbon dioxide 
(paCO2) by a Blood Gas and Electrolyte System (Radiometer ABL505, Copenhagen, Denmark). 
3.4. Evaluation of Behavioral Score 
Half of the rats in each group were scored 24 h after reperfusion on a 5-point scale based on the 
report of Zea et al. [33] with the following criteria: 0, no neurological symptoms; 1, unable to 
completely extend the front jaw on the other side; 2, rotating while crawling and falling to the 
contralateral side; 3, unable to walk without help; and 4, unconsciousness.  
3.5. Determination of Brain Infarction Volume  
After evaluation for behavioral scores, animals were anesthetized with chloral hydrate (10%). The 
whole brain was removed as quickly as possible and placed at −20 °C for 10 min. The brain tissue was 
divided into six 2-mm stions in a coronal plane. The ﬁrst stion was positioned at the middle line 
between the anterior pole and the optic chiasm. Afterwards, stions were simultaneously immersed in a 
2% TTC (2,3,5-triphenyltetrazolium chloride) solution (37 °C) for 30 min, followed by a 4% 
paraformaldehyde buffer for fixation. After 24 h, all stions were photographed using a digital camera 
(DC240; Kodak, USA). Imaging software (Adobe Photoshop 7.0) was employed to evaluate the 
infarction volume (pink areas were normal and pale areas implied ischemia). The total infarction 
volume was calculated as the sum of the infarct areas from each stion. In order to minimize the error 
introduced by edema, we used an indirect method to calculate the infarct volumes [34].  
Infarct volume = contralateral hemisphere region - non-infarcted region in the ipsilateral hemisphere 
Infarct percentage = Infarct volume/volume of the contralateral hemisphere × 100% 
3.6. Tissue Processing 
Half of the rats in each group were sacrificed 80 min after occlusion, and their brains were rapidly 
removed. The striatum was isolated and immediately frozen in liquid nitrogen until the next step.  
3.7. Reverse Transcription 
Stored tissue was homogenized with Trizol reagent (Invitrogen, Carlsbad, CA) for extraction of 
total RNA in accordance with the manufacturer’s protocol. Subsequently, a High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems) was used to complete the reverse transcription. Each 
tube contained a 20 µL reaction volume, which included 0.6 µg of total RNA (10 µL), 2 µL 10× RT 
buffer, 0.8 µL of 25× dNTP (100 mM), 2 µL 10× RT Random Primers and 50 units of MultiScribeTM 
Reverse Transcriptase. Tubes were heated for 10 min at 25 C, 2 h at 37 C and 5 s at 85 C. The 
samples were stored at -20 C until PCR ampliﬁcation. Int. J. Mol. Sci. 2010, 11                 
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3.8. Quantitative Real-Time PCR 
Gene-speciﬁc primers (sequences in Table 2) and SYBR® Green (Applied Biosystems, Foster City, 
CA) were used for real-time PCR quantification of NR2B and mGluR5 with an ABI PRISM 7000  
real-time thermal cycler. Primer Express software (Applied Biosystems) was employed to design 
oligonucleotide primers. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as the 
standardized control. 
Table 2. Primer sequences used for real-time RT-PCR. 
                    Gene Forward primer (5
,–3
,)                    Reverse primer (5
,–3
,) 
NR2B: TCCGTCTTTCTTATGTGGATATGC CCTCTAGGCGGACAGATTAAGG 
mGluR: 5 VCCCTAAGCTCCAACGGAAAAT VTGATGACCGCCGTTTGGT 
GAPDH: GGGCAGCCCAGAACATCA TGTCCGTATGGCTTCATTGATG 
The reaction settings were as follows: 1 cycle at 50 C (2 min), 1 cycle at 95 C (10 min) and  
40 cycles of 95 C for 15 s and 60 C for 1 min. Cycle threshold values were selected based on the 
linear range from log scaling and the baseline. The 20 µL reaction contained 2 µL of cDNA, 300 nM 
of each primer and 10 µL of SYBR® Green PCR Master Mix, which included AmpliTaq Gold DNA 
polymerase. Sequence Detector software (SDS version 1.6, Applied Biosystems) was used for 
detecting SYBR Green reporter dye ﬂuorescence. The relative change in the mRNA expression of the 
NR2B and mGluR5 following MCAO was calculated by the following equation [37]:   
Fold change = 2
-ΔCt; ΔCt = (Cttarget − CtGAPDH). 
3.9. Statistical Analysis 
Statistical analyses were performed with SPSS for Windows, version 11.0 (SPSS Inc, Chicago, IL). 
Differences in relative mRNA expression among the groups were analyzed using a one-way ANOVA 
followed by a post-hoc Tamhane multiple comparison test to compare the three groups (Table 3). 
Statistical signiﬁcance among behavioral scores and infarct volumes of the different experimental 
groups (exercise with occlusion and non-exercise with occlusion) was analyzed with an unpaired 
Student’s t-test. P < 0.05 was considered statistically significant. 
Table 3. Relative gene expression levels of NR2B and mGluR5. 
Group NR2B  mGluR5 
Sham  0.00182 ± 0.00026  0.01816 ± 0.00241 
Exercise  0.00070 ± 0.00004  0.00286 ± 0.00061 
Non-exercise  0.00335 ± 0.00076  0.01896 ± 0.00312 
The different glutamate receptor subunits normalized with respect to the GAPDH mRNAs of each 
animal are demonstrated. Data represent means ± S.E.M. (n = 6). 
4. Conclusions  
Our study indicated that pre-ischemic treadmill training lowered the mRNA levels of both NR2B 
and  mGluR5, which potentially induced BIT. Further study is needed to explore the possible Int. J. Mol. Sci. 2010, 11                 
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involvement of other glutamate receptors and transporters in this neuroprotective effect. Overall, our 
study demonstrated that appropriate physical exercise may be an effective method for ischemic 
preconditioning.  
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